| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Trinity Biotech plc
13D/A
Amendment 6
TRIB · 896438504
|
17.0% |
12/10/2025
Event 12/8/2025
|
|||
| MiCo IVD Holdings, LLC | 17.0% | ||||
| AI n M net Ltd. | 17.0% | ||||
| Joon Ho Lee | 17.0% | ||||
|
Trinity Biotech plc
13D/A
Amendment 5
TRIB · 896438504
|
17.0% |
12/4/2025
Event 12/2/2025
|
|||
| MiCo IVD Holdings, LLC | 17.0% | ||||
| AI n M net Ltd. | 17.0% | ||||
| Wonyong Park | 17.0% | ||||
|
Trinity Biotech plc
13D/A
Amendment 3
TRIB · 896438306
|
18.0% |
12/19/2024
Event 12/17/2024
|
|||
| MiCo IVD Holdings, LLC | 18.0% | ||||
| DAYLI TRINITY HOLDINGS, Ltd. | 18.0% | ||||
| DAYLI Fountainhead Project No.3 Private Equity Fund | 18.0% | ||||
| DAYLI Partners, Inc. | 18.0% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.